Southeast Clinical Oncology Research Consortium, Inc. (SCOR)

描述(由申请人提供)：SCCC-UpState是两个成功的传统CCOP的合并，它们被称为东南癌症控制联盟(SCCC)和Carolina北部(下称联盟)，由23个组件和63个子组件组成，位于美国东南部的五个州地区(GA、NC、SC、TN和VA)与位于NC温斯顿-塞勒姆的非临床行政办公室(AO)。该联盟通过向东南部农村地区提供服务消除了一个关键障碍。AO提供专业知识、监管支持、培训、教育和主要研究人员，使小型农村社区医院、私人诊所和个人从业者能够向其他患者提供临床试验。有了这种结构，农村中心将能够将学术产生的概念转化为现实世界。经济限制使大多数医院和私人诊所无法分配必要的资源来独立开展研究。过去30年来，这一结构在支持农村社区方面取得了成功。这是查尔斯·L·斯普尔医学博士的愿景，阿特金斯博士和比尔登博士一直在实施这一愿景，以便在患者的家庭社区进行临床试验。每个组成部分都有一名负责的调查员和协调员来组织和促进临床研究的参与。分布在86个治疗中心的232多名研究人员和140多名研究人员参与了各种社区环境下的研究工作。广阔的地理区域改善了增加NCI赞助的临床试验的机会。长期目标是：1)提供尖端临床试验；2)实施加强癌症护理服务的计划；3)在现有关系的基础上建立新的合作关系；4)积极招募参与者参加临床试验。这些组成部分的集水区面积超过950万，人口结构多样，其中包括大量的非裔美国人。NCI对这笔赠款的支持将允许有限的联邦资金在广阔的农村地理区域最大化，惠及农村和医疗服务不足的人口。

DESCRIPTION (provided by applicant): The SCCC-Upstate is a merger of two successful legacy CCOPs known as Southeast Cancer Control Consortium, Inc. (SCCC) and Upstate Carolina (hereafter the Consortium) comprised of 23 components and 63 sub-components, located in a five-state area of the Southeast US (GA, NC, SC, TN, and VA) with a nonclinical Administrative Office (AO) in Winston-Salem, NC. The Consortium eliminates a critical barrier by supplying service to the rural southeastern area. The AO provides expertise, regulatory support, training, education, and principal investigators to enable small rural community hospitals, private practices, and solo practitioners the ability to provide clinical trials to ther patients. With this structure, rural centers will be able to translate academic-generated concepts to the real world. Economic constraints prohibit most hospitals and private practices from allocating the required resources to conduct research independently. This structure has been successful in supporting rural communities for the past 30 years. This was the vision of Charles L Spurr, MD that has been carried on by Drs. Atkins and Bearden to make clinical trials available in the patient's home community. Each component has a responsible investigator and coordinator to organize and promote clinical research participation. Over 232 investigators and 140 research staff located at 86 treatment centers are involved in the delivery of research in a variety of community settings. The vast geographical area improves the opportunity to increase access of NCI-sponsored clinical trials. The long-term objectives are to: 1) provide cutting edge clinical trials; 2) implement programs to enhance cancer care delivery; 3) build on existing relationships and establish new collaborations; and 4) actively enroll participants to clinical trials. The catchment area of the components is over 9.5 million, with diverse demographics including a significant African American population. NCI support of this grant will allow restricted federal dollars to be maximized over a vast rural geographic area reaching rural and medically underserved populations.